Two Directors at Merck KGAA bought 7,949 shares at 103.531EUR. The significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
SRT is occupying the important market trends (especially biologics), whose growth is considered valid. The new medium-term forecast presented on 17.03.26 is, according to CEO M. Grosse, "realistic but ambitious." It aims for organic revenue growth (in cc) of 8 - 11% YoY from 2027 onwards for the coming years – about 100 - 200 BP YoY above market growth – (thus somewhat more moderate than "Sartorius 2028"). Both divisions are expected to contribute to this, with the bioprocess business (BPS) – as...
A director at Lonza Group AG bought/sold 239 shares at 506.800CHF and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Two Directors at Thermo Fisher Scientific Inc sold 413 shares at between 0.000USD and 541.200USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.